In addition, IBD patients have a high risk of gastrointestinal and other cancers resulting from chronic inflammation-induced tumor formation and long-term use of immunosuppressive drugs, such as azathioprine and anti-tumor necrosis factor (TNF) drugs, exerting carcinogenic action [7]. The gene discussed is TNF; the disease is inflammatory bowel disease.